UNSPSC 51302310: Democonazole

This classification denotes an antifungal agent with the molecular formula C19H15Cl3N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Z4E7E087J, chemically known as (e)-1-(2,4-dichloro-beta-(2-(p-chlorophenoxy)ethoxy)styryl)imidazole but generally known as democonazole, which bears US NIH Compound Identifier 3033986. European Medicines Agency schedules Democonazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06969MIG.

UNSPSC 51302310 Democonazole is a Commodity code that captures fungicide and antimycotic pharmaceutical products, though recent state and local procurement activity under this code does not align with the nominal scope. The City of Tampa Fire Rescue Department posted ITB 25-P-00157 on April 24, 2026, soliciting medical aid supplies including antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, first aid kits, and emergency blankets—items that fall outside the narrow pharmaceutical scope of a democonazole-specific code and suggest the code is being used as a catch-all or mislabeled category for broader medical supply procurement. The solicitation targets a one-year initial award with two optional one-year renewals, with a total department budget of $100,000 and estimated annual quantities ranging from 1 to 2,700 units per item depending on the line item. The City has established set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs), offering a 5% bid discount on total bid amount (capped at $10,000 for SLBEs and $20,000 for U-WMBEs), with priority targeting businesses owned by African American, Hispanic, Asian, Native American, and Women business owners.

The code shows limited recent activity and does not appear to be a primary vehicle for state and local fungicide procurement. The single identified opportunity comes from Tampa, Florida, and the mismatch between the code's nominal pharmaceutical scope and the actual medical supply items being solicited suggests the code may not reflect active demand for democonazole-specific products in state and local procurement pipelines. Vendors evaluating pursuit under this code should verify with the issuing body whether the code assignment reflects the actual product family being sought, as the source material does not support meaningful activity or geographic concentration under this Commodity code.